Glenmark Life Sciences Limited IPO Detail

2 minutes, 11 seconds Read

Glenmark Life Sciences Limited IPO [INITIAL PUBLIC OFFERING] Detail

Home » Stock Market » IPO » Glenmark Life Sciences Limited IPO Detail

About the Glenmark Life Sciences Limited

The company was incorporated as ‘Zorg Laboratories Private Limited’, a private limited company under the Companies Act, 1956 on June 23, 2011 at Pune and was granted the certificate of incorporation by the Registrar of Companies, Maharashtra at Pune (“RoC”). Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated July 4, 2018 and the name of the Company was changed to ‘Glenmark Life Sciences Private Limited’ pursuant to a special resolution passed by the shareholders of the Company on July 25, 2018 and a fresh certificate of incorporation dated August 10, 2018 was issued by the RoC. A shareholders’ resolution was passed on August 13, 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated August 28, 2018 was issued by the RoC.

Glenmark Life Science Limited IPO detail

Registered Office: Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213, Maharashtra, India;

Corporate Office: 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East, Mumbai – 400099, Maharashtra, India; Tel: +91 2189 234456/ +91 2189 234246 ;

Website: www.glenmarklifesciences.com;

Contact Person: Rudalf Corriea (Company Secretary and Compliance Officer);


Company Financials

Advertisements

Summary of Restated Consolidated Financial Information

For the year/period ended (in ₹ million)

Particulars
 31-Mar-2131-Mar-2031-Mar-19
Total Revenue18,859.7615,493.038,868.65
Profit After Tax3,515.813,130.981,955.92
Total Asset19,970.7517,256.0414,753.95


Glenmark Life Sciences Limited – IPO Details

IPO Details

Issue Open Date27 July 2021
Issue Close Date29 July 2021
Issue TypeBook Built Issue
Face Value₹ 2 per equity share
IPO/Issue Price ₹ 695 to ₹ 720 per equity share
Market Lot20 Shares
Min Order Quantity20 Shares
Listing AtBSE, NSE

IPO/ Issue Time Line [Tentative]

27 July 2021

Issue Open Date

Issue Close Date

29 July 2021
3rd Aug 2021

Basis of Allotment Date

Initiation of Refunds

4th Aug 2021
5th Aug 2021

Credit of Shares to Demat Account

IPO Listing Date

6th Aug 2021


Objects of the Issue

The Company proposes to utilize the Net Proceeds from the Offer towards funding the following objects:

1. Payment of outstanding purchase consideration to the Promoter for the spin-off of the API business from the Promoter into our Company pursuant to the Business Purchase Agreement dated October 9, 2018;

  1. Funding capital expenditure requirements; and

  1. General corporate purposes


IPO FAQs

When the Glenmark Life Sciences Limited IPO will Open?

The Glenmark Life Sciences Limited IPO opens on 27th July 2021.

When the Glenmark Life Sciences IPO will close?

The Glenmark Life Sciences Limited IPO opens on 29th July 2021.

What is the lot size of Glenmark Life Sciences IPO?

Glenmark Life Sciences (GLS) IPO lot size is 20 Shares and the minimum order quantity is 20 Shares.

What is the Issue Price (per equity share) of the IPO?

The issue price of the IPO ranges from ₹ 695 to ₹ 720 per equity share.

Also, read other articles @ EduTaxTuber

author

EduTaxTuber Team

We are here to help for every updates related to everything...👍📙👍📗

Similar Posts

Leave a Reply

Realme 10 Pro and 10 Pro+ Launched RBI Monetary Policy Highlights England vs Senegal: FIFA World Cup 2022 No Curfew in Mumbai: Section 144 Imposed to ensure Peace Elon Musk suspends Kanye West Twitter Account for inciting violence